New Evidence for Stroke Prevention
Open Access
- 18 September 2002
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 288 (11) , 1388-1395
- https://doi.org/10.1001/jama.288.11.1388
Abstract
Review from JAMA — New Evidence for Stroke Prevention — Scientific Review — ContextStroke is a major cause of morbidity and mortality, and the application of evidence for stroke prevention varies considerably.ObjectiveTo review the most recent, high-quality evidence for primary and secondary stroke prevention.Data Sources and Study SelectionSearches of MEDLINE, The Cochrane Library, and the ACP Journal Club were performed to identify English-language articles published from 1998 to 2001 that focused on primary and secondary stroke prevention. The references of each retrieved article were scanned, and experts in the field were contacted to identify additional relevant articles.Data ExtractionEach of the articles was appraised, and its quality was graded with levels of evidence based on specific scientific methods that affect a study's validity.Data SynthesisFor primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several randomized trials. Effective strategies for the secondary prevention of stroke include treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, antiplatelet therapy, and carotid endarterectomy in patients with severe carotid artery stenosis.ConclusionsStroke is a major public health concern, and a significant body of evidence supports many primary and secondary prevention strategies.Keywords
This publication has 37 references indexed in Scilit:
- US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic StrokeStroke, 1995
- Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implicationsArchives of internal medicine (1960), 1995
- Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk.Stroke, 1994
- Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.Stroke, 1994
- Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. The SPRINT Study Group.Stroke, 1993
- The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention TrialNew England Journal of Medicine, 1989
- Meta-analysis of relation between cigarette smoking and stroke.BMJ, 1989
- Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham StudyArchives of internal medicine (1960), 1987
- Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart DiseaseBMJ, 1964